Roquefort Therapeutics (LSE:ROQ) Accounts Payable : £0.15 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Roquefort Therapeutics Accounts Payable?

Roquefort Therapeutics's Accounts Payable for the quarter that ended in Dec. 2023 was £0.15 Mil.

Roquefort Therapeutics's quarterly Accounts Payable increased from Dec. 2022 (£0.07 Mil) to Jun. 2023 (£0.28 Mil) but then declined from Jun. 2023 (£0.28 Mil) to Dec. 2023 (£0.15 Mil).

Roquefort Therapeutics's annual Accounts Payable increased from Dec. 2021 (£0.04 Mil) to Dec. 2022 (£0.07 Mil) and increased from Dec. 2022 (£0.07 Mil) to Dec. 2023 (£0.15 Mil).

Roquefort Therapeutics Accounts Payable Historical Data

The historical data trend for Roquefort Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Accounts Payable Chart

Roquefort Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Accounts Payable

0.04

0.07

0.15

Roquefort Therapeutics Semi-Annual Data
	Jun21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	0.01	0.04	0.07	0.28	0.15

Roquefort Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Roquefort Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Roquefort Therapeutics (LSE:ROQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

ROQAF:USA

Address

85 Great Portland Street, First Floor, London, GBR, W1W 7LT

Website

https://www.roquefortplc.com

Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses that are at an early stage in the medical sector including Drug and vaccine development; Diagnostics; Immuno-therapy; and Cell and gene therapies. The principal activity of the Company is to develop pre-clinical next generation medicines focused on hard to treat cancers.

Roquefort Therapeutics (LSE:ROQ) Headlines

No Headlines